Recent studies investigate Phexxi for various potential indications

Video

Bassem Maximos, MD, MPH, FACOG, discusses 2 recent studies investigating nonhormomal contraceptive gel Phexxi (Evofem Biosciences) for the potential treatment of UTIs and improvement in sexual satisfaction.

**Editors note: In an earlier version of this video, Dr. Maximos explained that 77% of women on study/using Phexxi suffered a UTI. The data actually shows that 77 women out of 1339 study subjects suffered a UTI, a notable decrease in UTIs in women using Phexxi. The video has since been edited to reflect this correction.

Recent Videos
Lisa Bayer, MD, MPH
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Giovanni Traverso, PhD, highlights contraceptive implants through small needle | Image Credit: meche.mit.edu
Ryan Haumschild, PharmD
How the Flyte device revolutionizes SUI management | Image Credit: linkedin.com.
Dr. Wanda Filer discusses how to overcome barriers to SUI treatment | Image Credit: linkedin.com.
Revi System shows efficacy against urgency urinary incontinence | Image Credit: ics.org.
New pSNM system empowers patients in urge urinary incontinence treatment | Image Credit: trinityhealthmichigan.org.
Jannah Thompson, MD, highlights battery free device for UUI management | Image Credit: trinityhealthmichigan.org
Dr. Somi Javaid provides advice for sexual health care | Image Credit: hermd.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.